Cue Biopharma, Inc. (CUE) Social Stream
CUE BIOPHARMA INC (CUE) Price Targets From Analysts
Use the tables below to see what analysts covering CUE BIOPHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-17 | 4 | $32 | $26 | $29 | $4 | 625% |
| 2021-11-15 | 4 | $32 | $28 | $30 | $4 | 650% |
| 2022-01-13 | 4 | $32 | $20 | $27.333 | $4 | 583.32% |
| 2022-03-18 | 3 | $32 | $20 | $27.333 | $4 | 583.32% |
| 2022-03-20 | 3 | $26 | $20 | $23.333 | $4 | 483.32% |
| 2022-06-07 | 2 | $26 | $20 | $23 | $4 | 475% |
| 2022-08-05 | 2 | $26 | $10 | $18 | $4 | 350% |
| 2022-11-15 | 2 | $10 | $9 | $9.5 | $4 | 137.5% |
| 2023-03-21 | 3 | $10 | $7 | $8.666 | $4 | 116.65% |
| 2023-05-10 | 3 | $10 | $7 | $8.333 | $4 | 108.33% |
The Trend in the Analyst Price Target
Over the past 36 months, CUE's average price target has gone down $23.47.
CUE reports an average of 203.67% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-05 | 2 | 26 | 10 | 18.000 | 3.04 | 492.11% |
| 2022-08-24 | 2 | 10 | 10 | 10.000 | 3.01 | 232.23% |
| 2023-02-22 | 3 | 10 | 7 | 8.666 | 3.17 | 173.38% |
| 2023-03-22 | 3 | 10 | 7 | 8.333 | 3.31 | 151.75% |
| 2023-05-10 | 3 | 10 | 7 | 8.333 | 4.73 | 76.17% |
CUE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 26 weeks, CUE's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how CUE BIOPHARMA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 135.52% of that group.
- In the context of all US stocks, CUE BIOPHARMA INC's upside potential (average analyst target price relative to current price) is higher than 1421.87% of them.
- In terms of how CUE BIOPHARMA INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -190.91% of that group.
- CUE has a higher average analyst price target than 834.62% of stocks in the small market cap category.
Stocks similar to CUE BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENSC, NRXP, and ZOM.
View All Top Stocks by Price Target
What is the outlook for CUE? Use POWR Ratings for clearer insight into price direction.